CD8A and neoplasm: The results revealed that PGRN–/– CD8+ T cells displayed stronger killing activity in an E:T ratio-dependent manner than WT CD8+ T cells, with a peak difference at an E:T ratio of 10:1 and a tumor cell-killing rate of approximately 1.5 times greater at that time (Fig. 2I, J).